WS #3092

The Middle East conflict narrative has shifted from de-escalation optimism to renewed escalation, with Iran dismissing the U.S. ceasefire plan and setting hardened preconditions for negotiations, directly contradicting the previous synthesis's market optimism. This is corroborated by Ukraine targeting Russian oil infrastructure and the deployment of U.S. 82nd Airborne elements to the region, signaling heightened military tensions. Concurrently, a market survey indicates 54% expect a U.S.-Iran ceasefire by end-April but 41% believe Strait of Hormuz normalization won't occur until Q3 or later, with Brent crude expected to stay above $100, suggesting persistent energy supply risks. Kuwait airspace remains closed per Jazeera Airways, further disrupting regional logistics. These developments offset the previous peace plan optimism, dampening the bearish energy signal from earlier price drops and reintroducing volatility in energy and defense sectors. In corporate news, analyst actions show mixed sentiment: Nike and RH face price target cuts, while Ionis Pharmaceuticals and Strata Critical Medical receive bullish upgrades. Trading halts for FGL and HSPT due to volatility pauses indicate market stress in specific names, though broader indices (SPY +0.08%, QQQ +0.01%) show minimal movement in the price context.